Drooid Logo
Back to story perspectives

Full Breakdown

Death of Influencer Igho Ubiribo Triggers Thai Investigation into Cosmetic Procedure

9/10/2026, 2:37:24 AM

Core Event

On March 6, 43-year-old Igho Ubiribo—a Nigerian-born British businessman and Instagram influencer with 185,000 followers—died in Bangkok after receiving a hyaluronic-acid filler injection for penile enlargement. A London coroner determined the injection caused his death. Ubiribo collapsed with chest pains during a post-procedure massage, was taken to hospital with a suspected pulmonary embolism, and was declared dead around 1 a.m. after more than 100 minutes of resuscitation attempts.

Background & Context

Ubiribo had been a regular client of the Bangkok clinic since 2024, undergoing five filler injections. The first four procedures were performed in 2024 and 2025; on March 5 he received a single 40-millilitre dose, despite the doctor’s recommendation to split the treatment. Thailand, a leading destination for medical tourism, hosts roughly 7,000 aesthetic clinics—including about 2,000 in Bangkok—and the aesthetic market is projected to reach $7.51 billion (€6.4 billion) in 2027, three times its 2020 size.

Official Statements & Responses

Senior Bangkok police official Utit Soodjai confirmed that police are investigating the clinic’s licensing and safety compliance.

Data & Statistics

  • Five penile-enlargement injections administered to Ubiribo (first four in 2024-2025, fifth on March 5).
  • 40 millilitres of hyaluronic-acid filler delivered in the final session.
  • Thailand’s aesthetic sector: ~7,000 clinics, 2,000 in Bangkok; market forecast $7.51 billion in 2027.

Why It Matters

Ubiribo’s death has reignited debate over the safety of medical-tourism procedures in Thailand. Authorities’ investigation focuses on licensing and protocol adherence, highlighting the need for stricter oversight as the country’s cosmetic-procedure market expands rapidly. The outcome may influence international confidence in Thailand’s health-tourism reputation and could prompt regulatory reforms to protect foreign patients.